$FREY
FREYR Battery, Inc. /DE/

2024 Q4 Form 10-Q Financial Statement

#000199224324000157 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $26.67M
YoY Change 6.17%
% of Gross Profit
Research & Development $8.616M $7.090M
YoY Change 21.52% 118.15%
% of Gross Profit
Depreciation & Amortization $2.500M $1.190M
YoY Change 110.08% 981.82%
% of Gross Profit
Operating Expenses $31.79M $34.86M
YoY Change -8.81% 22.83%
Operating Profit -$31.79M -$35.01M
YoY Change -9.21%
Interest Expense $1.074M -$2.080M
YoY Change -151.63% -155.91%
% of Operating Profit
Other Income/Expense, Net $4.232M $26.94M
YoY Change -84.29% -138.94%
Pretax Income -$27.56M -$10.00M
YoY Change 175.56% -89.34%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.48M -$9.790M
YoY Change 180.64% -89.57%
Net Earnings / Revenue
Basic Earnings Per Share -$0.20 -$0.07
Diluted Earnings Per Share -$0.20 -$0.07
COMMON SHARES
Basic Shares Outstanding 140.5M shares 140.5M shares 139.7M shares
Diluted Shares Outstanding 140.5M shares 139.7M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $299.4M
YoY Change -28.1%
Cash & Equivalents $181.9M $299.4M
Short-Term Investments
Other Short-Term Assets $12.58M $41.50M
YoY Change -69.68% 98.56%
Inventory
Prepaid Expenses $2.838M
Receivables
Other Receivables
Total Short-Term Assets $199.5M $340.9M
YoY Change -41.49% -22.04%
LONG-TERM ASSETS
Property, Plant & Equipment $368.3M $372.6M
YoY Change -1.14% 261.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $791.0K $22.50M
YoY Change -96.48% 1150.0%
Other Assets $10.00K $0.00
YoY Change
Total Long-Term Assets $415.5M $397.9M
YoY Change 4.43% 217.3%
TOTAL ASSETS
Total Short-Term Assets $199.5M $340.9M
Total Long-Term Assets $415.5M $397.9M
Total Assets $615.0M $738.8M
YoY Change -16.76% 31.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.08M $18.80M
YoY Change -46.38% 422.22%
Accrued Expenses $21.25M $27.80M
YoY Change -23.55% -18.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.35M $48.40M
YoY Change -35.22% 2.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $27.45M $56.00M
YoY Change -50.99% -46.46%
Total Long-Term Liabilities $27.45M $56.00M
YoY Change -50.99% -46.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.35M $48.40M
Total Long-Term Liabilities $27.45M $56.00M
Total Liabilities $76.30M $106.5M
YoY Change -28.36% -29.84%
SHAREHOLDERS EQUITY
Retained Earnings -$358.0M
YoY Change
Common Stock $1.405M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $538.7M $632.3M
YoY Change
Total Liabilities & Shareholders Equity $615.0M $738.8M
YoY Change -16.76% 31.3%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$27.48M -$9.790M
YoY Change 180.64% -89.57%
Depreciation, Depletion And Amortization $2.500M $1.190M
YoY Change 110.08% 981.82%
Cash From Operating Activities -$19.26M
YoY Change -14.63%
INVESTING ACTIVITIES
Capital Expenditures $40.45M
YoY Change -21.1%
Acquisitions
YoY Change
Other Investing Activities $3.510M
YoY Change -37.21%
Cash From Investing Activities -$36.95M
YoY Change -19.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -19.26M
Cash From Investing Activities -36.95M
Cash From Financing Activities 0.000
Net Change In Cash -56.21M
YoY Change -17.63%
FREE CASH FLOW
Cash From Operating Activities -$19.26M
Capital Expenditures $40.45M
Free Cash Flow -$59.71M
YoY Change -19.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139705000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1405000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-484000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-208000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35011000 usd
us-gaap Operating Expenses
OperatingExpenses
97368000 usd
us-gaap Operating Expenses
OperatingExpenses
103908000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31788000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35011000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-97368000 usd
CY2024Q3 frey Warrant Liability Fair Value Adjustment Gain Loss
WarrantLiabilityFairValueAdjustmentGainLoss
1096000 usd
CY2023Q3 frey Warrant Liability Fair Value Adjustment Gain Loss
WarrantLiabilityFairValueAdjustmentGainLoss
24399000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1284000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3627000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6042000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-110000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3213000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1245000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2172000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2537000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4232000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-33718000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
674973000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3688000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-25403000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
327861000 usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
333-274434
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
FREYR Battery, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-3205861
dei Entity Address Address Line1
EntityAddressAddressLine1
6&8 East Court Square, Suite 300,
dei Entity Address City Or Town
EntityAddressCityOrTown
Newnan
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30263
dei City Area Code
CityAreaCode
678
dei Local Phone Number
LocalPhoneNumber
632-3112
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
140490406 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181851000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253339000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2202000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
22403000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2838000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2168000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
34044000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
199474000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
311954000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368342000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
366357000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2813000 usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
22303000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22640000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24476000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4282000 usd
CY2024Q3 us-gaap Assets
Assets
614985000 usd
CY2023Q4 us-gaap Assets
Assets
732185000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10080000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21254000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30790000 usd
CY2024Q3 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
19000 usd
CY2023Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
281000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31353000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49184000 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
721000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2025000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16775000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18816000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27446000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27444000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
76295000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
97469000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
355000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
355000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140490000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139705000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1397000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
925623000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34035000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18826000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-358004000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-274999000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
538690000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
0 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
538690000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
634716000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
614985000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
732185000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18515000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27772000 usd
CY2024Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
21819000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18113000 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140490000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
633195000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1521000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85405000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8616000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7086000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30854000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18295000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001992243
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
12583000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
929324000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61386000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
4507000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
4644000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-150000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-153000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
31788000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-103908000 usd
frey Warrant Liability Fair Value Adjustment Gain Loss
WarrantLiabilityFairValueAdjustmentGainLoss
1294000 usd
frey Warrant Liability Fair Value Adjustment Gain Loss
WarrantLiabilityFairValueAdjustmentGainLoss
23248000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1074000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
20546000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7806000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6103000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25007000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13972000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
55939000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27556000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10004000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83396000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47969000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-27556000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-10004000 usd
us-gaap Profit Loss
ProfitLoss
-83407000 usd
us-gaap Profit Loss
ProfitLoss
-48310000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-81000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-219000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-402000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-517000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-27475000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9785000 usd
us-gaap Net Income Loss
NetIncomeLoss
-83005000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47793000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140490000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140490000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139705000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139705000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140102000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140102000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139705000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139705000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-27556000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-10004000 usd
us-gaap Profit Loss
ProfitLoss
-83407000 usd
us-gaap Profit Loss
ProfitLoss
-48310000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5973000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6134000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15209000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48009000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21583000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3870000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-98616000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-96319000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-81000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-219000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-402000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-517000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21502000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3651000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-98214000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95802000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
720127000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1462000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-12903000 usd
CY2023Q1 frey Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability Classified To Equity Classified
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityClassifiedToEquityClassified
5000 usd
CY2023Q2 frey Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability Classified To Equity Classified
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityClassifiedToEquityClassified
56000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20425000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
632889000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5421000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-10004000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6134000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
634440000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
634716000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3670000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-28690000 usd
CY2024Q1 frey Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability Classified To Equity Classified
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityClassifiedToEquityClassified
10000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-26044000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
583662000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1486000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-27161000 usd
CY2024Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4862000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562849000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1554000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-27556000 usd
CY2024Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
4130000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5973000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
538690000 usd
us-gaap Profit Loss
ProfitLoss
-83407000 usd
us-gaap Profit Loss
ProfitLoss
-48310000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6449000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7859000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7028000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1922000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1282000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1005000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1294000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-23248000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-484000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-208000 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
1075000 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
19346000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
929000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1672000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-429000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28401000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1626000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3212000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72575000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53978000 usd
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
22735000 usd
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 usd
frey Proceeds From Property Related Grants
ProceedsFromPropertyRelatedGrants
0 usd
frey Proceeds From Property Related Grants
ProceedsFromPropertyRelatedGrants
3500000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34683000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168811000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1655000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11948000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167966000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4130000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4130000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3036000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13240000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-91689000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-235184000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
275742000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
563045000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184053000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
327861000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
6133000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
11187000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181851000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
299419000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2202000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
28442000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184053000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Use of Estimates</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. </span>Estimates and assumptions include, but are not limited to, estimates related to impairment of long-lived assets, the valuation of warrant liability, and share-based compensation. We base these estimates on historical experiences and on various other assumptions that we believe are reasonable under the circumstances, however, actual results may differ materially from these estimates.
us-gaap Severance Costs1
SeveranceCosts1
4500000 usd
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
4500000 usd
CY2023 us-gaap Severance Costs1
SeveranceCosts1
6000000 usd
CY2024Q3 frey Deposits Receivable
DepositsReceivable
4146000 usd
CY2023Q4 frey Deposits Receivable
DepositsReceivable
23893000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
8437000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
10151000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
12583000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
34044000 usd
CY2024Q3 us-gaap Land
Land
44326000 usd
CY2023Q4 us-gaap Land
Land
44326000 usd
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
39803000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
39723000 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
33535000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14058000 usd
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2852000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2926000 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
258591000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
269197000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
379107000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
370230000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10765000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3873000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368342000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
366357000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
2500000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1100000 usd
us-gaap Depreciation
Depreciation
7000000.0 usd
us-gaap Depreciation
Depreciation
1800000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
150000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
150000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
150000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
150000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
150000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
791000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1275000 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21028000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21028000 usd
CY2024Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
21819000 usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
22303000 usd
CY2024Q3 frey Accrued Purchases Current
AccruedPurchasesCurrent
8067000 usd
CY2023Q4 frey Accrued Purchases Current
AccruedPurchasesCurrent
13145000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7961000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13120000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3348000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3382000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1878000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1143000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21254000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30790000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
24600000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
24600000 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
355000000.0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
355000000.0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140500000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140500000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139700000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139700000 shares
CY2024Q3 frey Common Stock Number Of Vote Units
CommonStockNumberOfVoteUnits
1 vote
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000.0 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000.0 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
200000 usd
us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
400000 usd
CY2023Q3 us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
100000 usd
us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
200000 usd
CY2023Q4 us-gaap Government Assistance Liability Current
GovernmentAssistanceLiabilityCurrent
200000 usd
CY2024Q3 us-gaap Government Assistance Liability Current
GovernmentAssistanceLiabilityCurrent
200000 usd
CY2023Q4 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
27000000.0 usd
CY2024Q3 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
27000000.0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
frey Number Of Board Member Engaged In Consulting Agreements
NumberOfBoardMemberEngagedInConsultingAgreements
2 director
CY2024Q2 frey Number Of Consulting Agreements
NumberOfConsultingAgreements
1 agreement
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-27475000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27475000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9785000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9785000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83005000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-83005000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47793000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-47793000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140490000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140490000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139705000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139705000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140102000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140102000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139705000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139705000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44497000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37714000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44497000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37714000 shares
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001992243-24-000157-index-headers.html Edgar Link pending
0001992243-24-000157-index.html Edgar Link pending
0001992243-24-000157.txt Edgar Link pending
0001992243-24-000157-xbrl.zip Edgar Link pending
ex311-q32024.htm Edgar Link pending
ex312-q32024.htm Edgar Link pending
ex321-q32024.htm Edgar Link pending
ex322-q32024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
frey-20240930.htm Edgar Link pending
frey-20240930.xsd Edgar Link pending
frey-20240930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
frey-20240930_cal.xml Edgar Link unprocessable
frey-20240930_def.xml Edgar Link unprocessable
frey-20240930_lab.xml Edgar Link unprocessable
frey-20240930_pre.xml Edgar Link unprocessable
frey-20240930_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable